Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

February
27
2026

Beyond the Billing Code: What the New 2026 CMS Standards Mean for Non-Invasive Skin Cancer Treatment

Skin cancer rates continue to increase, with the American Dermatology Association most recently estimating that one in five Americans will experience skin cancer in their lifetime. As skin cancer rates rise, so does the demand…

February
26
2026

Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100™ Installed Base

Proprietary cloud-based software and add-on solution designed to provide current and future SRT-100 users with enhanced workflow, operating intelligence and clinical utility Creates a scalable, recurring-revenue opportunity for Sensus tied to treatment workflows and necessary…

February
18
2026

Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology

New financing program provides a “one-stop” pathway for practices to acquire systems through outright purchase or several attractive leasing alternatives Supports improved conversion of late-stage prospects as reimbursement clarity accelerates purchase decisions and lowers breakeven…

February
17
2026

CMS Reimbursement for Tech-Enabled Therapies with Joseph C. Sardano from Sensus Healthcare

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy